mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.08 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.08 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.09 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.09 |